Theranostics Market
The theranostics market involves a medical approach that combines diagnostics and therapy to deliver personalized treatment for specific diseases. Key customers include hospitals, diagnostic laboratories, and research institutes that utilize these integrated methods. The market's growth is driven by the rising prevalence of chronic conditions like cancer, significant advancements in molecular imaging technologies, and the increasing adoption of precision medicine.
CAGR
15.5%
Compound Annual Growth Rate
Current Value
$2.73B
Estimated 2026
Projected Value
$8.64B
By 2034